Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05597891 · ClinicalTrials.gov registry record · NA
Endovascular Engineering ENGULF Study
A NA study of Pulmonary Embolism, sponsored by Endovascular Engineering.
- Recruiting
- Registry status
- NA
- Development phase
- 181
- Enrollment target
- 19
- Study locations
NCT05597891 is a NA study of Pulmonary Embolism that is actively recruiting participants, run by Endovascular Engineering. The registered enrollment target is 181 participants, below the 3,055-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (94% lower). The trial reports 19 study locations across 10 states.
The verdict
NCT05597891, a NA study of Pulmonary Embolism, is actively recruiting participants, sponsored by Endovascular Engineering.
- RECRUITING
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
- 19
- Study locations
Study Summary
Evaluation of initial safety and clinical feasibility of the Hēlo PE Thrombectomy System for thrombectomy in acute submassive pulmonary embolism (PE).
Conditions Studied
Interventions
- DEVICE Hēlo PE Thombectomy System
Study Locations (19)
California
- Huntington Hospital - Pasadena
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center - Torrance
- Torrance Memorial Medical Center - Torrance
Florida
- Delray Medical Center - Delray Beach
- Baptist Health Research Institute - Jacksonville
- HCA Florida Memorial Hospital - Jacksonville
Texas
- Austin Heart - Austin
- Baylor Scott & White Research Institute - Dallas
- UT Health - Houston
Georgia
- Piedmont Heart - Atlanta
- Northside Hospital - Atlanta
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Brigham and Women's Hospital - Boston
Tennessee
- Wellmont Cardiology Services / Ballad Health - Kingsport
- Tennova Healthcare - Turkey Creek Medical Center - Knoxville
Indiana
- Indiana University - Indianapolis
Ohio
- TriHealth Hatton Research Institute - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2023-01-12 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05597891
The ClinicalTrials.gov registry entry for NCT05597891 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,055-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (94% lower). The listed sponsor is Endovascular Engineering, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Hēlo PE Thombectomy System is the first listed.
NCT05597891 reports 19 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT05597891 about?
NCT05597891 is a clinical study titled "Endovascular Engineering ENGULF Study". Evaluation of initial safety and clinical feasibility of the Hēlo PE Thrombectomy System for thrombectomy in acute submassive pulmonary embolism (PE).
What is the current status of trial NCT05597891?
This trial is currently recruiting. It is a NA study. The enrollment target is 181 participants. The study started on 2023-01-12. Estimated completion is 2025-09-30.
What conditions does trial NCT05597891 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT05597891?
The interventions under investigation include: Hēlo PE Thombectomy System (DEVICE).
Who is sponsoring clinical trial NCT05597891?
This trial is sponsored by Endovascular Engineering, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05597891 being conducted?
This trial has 19 study locations across California, Florida, Georgia, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.